208 related articles for article (PubMed ID: 15071271)
1. Enhancing specificity without sacrificing sensitivity: potential benefits of using microvolt T-wave alternans testing to risk stratify the MADIT-II population.
Cohen RJ
Card Electrophysiol Rev; 2003 Dec; 7(4):438-42. PubMed ID: 15071271
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
[TBL] [Abstract][Full Text] [Related]
3. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT
Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804
[TBL] [Abstract][Full Text] [Related]
4. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.
Chow T; Kereiakes DJ; Onufer J; Woelfel A; Gursoy S; Peterson BJ; Brown ML; Pu W; Benditt DG;
J Am Coll Cardiol; 2008 Nov; 52(20):1607-15. PubMed ID: 18992649
[TBL] [Abstract][Full Text] [Related]
5. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.
Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung E; Menon S; Nallamothu BK; Chan PS
J Am Coll Cardiol; 2007 Jan; 49(1):50-8. PubMed ID: 17207722
[TBL] [Abstract][Full Text] [Related]
6. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.
Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS
J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307
[TBL] [Abstract][Full Text] [Related]
7. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
[TBL] [Abstract][Full Text] [Related]
8. Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?
Armoundas AA; Hohnloser SH; Ikeda T; Cohen RJ
Nat Clin Pract Cardiovasc Med; 2005 Oct; 2(10):522-8. PubMed ID: 16186850
[TBL] [Abstract][Full Text] [Related]
9. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
Filion KB; Xie X; van der Avoort CJ; Dendukuri N; Brophy JM
Int J Technol Assess Health Care; 2009 Apr; 25(2):151-60. PubMed ID: 19331707
[TBL] [Abstract][Full Text] [Related]
10. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.
Bloomfield DM; Bigger JT; Steinman RC; Namerow PB; Parides MK; Curtis AB; Kaufman ES; Davidenko JM; Shinn TS; Fontaine JM
J Am Coll Cardiol; 2006 Jan; 47(2):456-63. PubMed ID: 16412877
[TBL] [Abstract][Full Text] [Related]
11. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.
Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Sędkowska A; Cebula S; Musialik-Łydka A; Kalarus Z
Kardiol Pol; 2012; 70(5):447-55. PubMed ID: 22623232
[TBL] [Abstract][Full Text] [Related]
12. Value of microvolt T-wave alternans for predicting patients who would benefit from implantable cardioverter-defibrillator therapy.
Haghjoo M; Arya A; Sadr-Ameli MA
Cardiol Rev; 2006; 14(4):173-9. PubMed ID: 16788329
[TBL] [Abstract][Full Text] [Related]
13. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
Coats AJ
Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
[TBL] [Abstract][Full Text] [Related]
14. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.
Baravelli M; Salerno-Uriarte D; Guzzetti D; Rossi MC; Zoli L; Forzani T; Salerno-Uriarte JA
Int J Cardiol; 2005 Oct; 105(1):53-7. PubMed ID: 16207545
[TBL] [Abstract][Full Text] [Related]
15. [Positive microvolt T-wave alternans as a marker of ventricular arrhythmia trigering during cardioverter-defibrillator implantation].
Wierzbowski R; Michałkiewicz D; Cholewa M; Jacewicz K; Gniłka A; Adamus J
Pol Merkur Lekarski; 2006 Oct; 21(124):310-3. PubMed ID: 17205766
[TBL] [Abstract][Full Text] [Related]
16. The problem of indeterminate microvolt T-wave alternans results in patients with left ventricular dysfunction referred for implantable cardioverter-defibrillator implantation in the primary prevention of sudden cardiac death.
Daniłowicz Szymanowicz L; Szwoch M; Kempa M; Raczak G
Kardiol Pol; 2012; 70(8):795-802. PubMed ID: 22933211
[TBL] [Abstract][Full Text] [Related]
17. Evidence regarding clinical use of microvolt T-wave alternans.
Hohnloser SH; Ikeda T; Cohen RJ
Heart Rhythm; 2009 Mar; 6(3 Suppl):S36-44. PubMed ID: 19168396
[TBL] [Abstract][Full Text] [Related]
18. Do Beta-blockers impact microvolt T-wave alternans testing in patients at risk for ventricular arrhythmias? A meta-analysis.
Chan PS; Gold MR; Nallamothu BK
J Cardiovasc Electrophysiol; 2010 Sep; 21(9):1009-14. PubMed ID: 20384655
[TBL] [Abstract][Full Text] [Related]
19. Ability of microvolt T-wave alternans to modify risk assessment of ventricular tachyarrhythmic events: a meta-analysis.
Gupta A; Hoang DD; Karliner L; Tice JA; Heidenreich P; Wang PJ; Turakhia MP
Am Heart J; 2012 Mar; 163(3):354-64. PubMed ID: 22424005
[TBL] [Abstract][Full Text] [Related]
20. "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.
Kaufman ES; Bloomfield DM; Steinman RC; Namerow PB; Costantini O; Cohen RJ; Bigger JT
J Am Coll Cardiol; 2006 Oct; 48(7):1399-404. PubMed ID: 17010802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
